Improving access to advanced diabetes technology for people with Type 1 Diabetes
Implementing Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
This study is testing a new system to help doctors prescribe advanced diabetes tools more fairly for people with Type 1 Diabetes, especially focusing on reducing differences in access for non-white patients.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1178 (estimated) |
| Ages | 2 Years to 95 Years |
| Sex | All |
| Sponsor | T1D Exchange, United States Academic / other |
| Locations | 2 sites (Boston, Massachusetts and 1 other locations) |
| Trial ID | NCT06931275 on ClinicalTrials.gov |
What this trial studies
This study aims to create a standardized system within electronic medical records (EMRs) to ensure equitable prescription and documentation of advanced diabetes technologies for individuals with Type 1 Diabetes (T1D). It will implement an EMR-based Best Practice Advisory (BPA) to guide healthcare providers in prescribing continuous glucose monitoring and automated insulin delivery systems. The study will assess whether this BPA can effectively reduce racial disparities in the use of these technologies and will gather insights from patients regarding their experiences and perspectives. The effectiveness will be evaluated by comparing ADT use among non-white patients at intervention centers versus matched control centers over a 12-month period.
Who should consider this trial
Good fit: Ideal candidates include non-Hispanic Black and Hispanic individuals aged 2 years and older with a diagnosis of Type 1 Diabetes for at least 6 months.
Not a fit: Patients who are already using advanced diabetes technologies at baseline will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce racial disparities in access to advanced diabetes technologies for patients with Type 1 Diabetes.
How similar studies have performed: Other studies have shown success in using EMR-based interventions to improve healthcare equity, making this approach promising but still relatively novel in the context of diabetes technology.
Eligibility criteria
Show full inclusion / exclusion criteria
Age ≥ 2 years with an EMR diagnosis of T1D for at least 6 months at baseline and receiving care at one of six intervention centers or a matched control at another T1DX-QI center. Inclusion Criteria: * non-Hispanic Black and Hispanic individuals Exclusion Criteria: * PwT1D with evidence of use of AID at baseline
Where this trial is running
Boston, Massachusetts and 1 other locations
- T1D Exchange — Boston, Massachusetts, United States (Recruiting)
- T1D Exchange — Boston, Massachusetts, United States (Not_yet_recruiting)
Study contacts
- Principal investigator: Osagie Ebekozien — T1DExchange
- Study coordinator: Osagie Ebekozien, MD
- Email: oebekozein@t1dexchange.org
- Phone: 857-205-2388
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.